Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Prof. Philip Hawkins, FMedSci
Healthcare Professional / Researcher Clinical Director
Division of Medicine
University College London
Gower Street
London, United Kingdom
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers
High prevalence of intracardiac thrombi in cardiac amyloidosis
Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis
Related Content
-
The ABCs of Amyloidosis: The Journey From Diagnosis to TreatmentThis article is for people who have amyl...
-
Daniel P. Judge, MDDr. Daniel Judge is a cardiology special...
-
Systemic Amyloidosis With Gastrointestinal Involvement: Diagnosis From Endoscopic and Histological ViewsAmyloid tends to deposit in the gastroin...
-
Martha Grogan, MDMartha Grogan is a Cardiologist-Internis...
-
Paul Cheng, MD, PhDDr. Cheng is a Cardiologist and Instru...
-
Amyloidosis now a hot topic in cardiac imaging due to new drug treatmentJuly 11, 2023 | Cardiovascular Business ...
-
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloido...Cardiac amyloidosis is emerging as an un...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.